Dietary Reversal of the Reprometabolic Syndrome
LFD
1 other identifier
interventional
30
1 country
1
Brief Summary
This study proposes to test the specific question that a eucaloric, low-fat diet given to women with obesity will result in an increase in reproductive hormones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2024
CompletedFirst Submitted
Initial submission to the registry
November 11, 2025
CompletedFirst Posted
Study publicly available on registry
November 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2029
November 14, 2025
November 1, 2025
4.4 years
November 11, 2025
November 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Urinary Pregnadiol Glucouronide concentration in ug/mg creatinine
From enrollment for 4 months post enrollment
Secondary Outcomes (1)
Amount of Urinary estrogen
From enrollment to 4 months
Study Arms (1)
Low-Fat Diet
EXPERIMENTALParticipants will eat a customized, eucaloric low-fat diet for one month
Interventions
Participants will eat a one-month eucaloric high-fat diet.
Eligibility Criteria
You may qualify if:
- Normal TSH and prolactin
- Regular menstrual cycles every 25-40 days
- No history of chronic disease affecting hormone production, metabolism or clearance
- No use of reproductive hormones, or medications/supplements known to impact them, within 3 months of enrollment
- Use of a reliable method of contraception (female or male partner sterilization, IUD, abstinence, diaphragm or cervical cap)
- Normal ovarian reserve (AMH of 0.5ng/ml or greater)
- Normal testosterone levels at screening or absence of clinical evidence of hyperandrogenemia (acne, facial hirsutism \[defined as Ferriman-Gallwey score\>8\] or alopecia)
You may not qualify if:
- Baseline dietary assessment indicative of 28% or less daily calories from fat
- Inability to comply with the protocol (many meals per week eaten outside of the home, frequent travel)
- Pregnancy or planned pregnancy within next 6 months at time of screening
- HbA1C \>6.5%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado School of Medicine
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nanette Santoro, MD
University of Colorado School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 11, 2025
First Posted
November 13, 2025
Study Start
August 10, 2024
Primary Completion (Estimated)
December 30, 2028
Study Completion (Estimated)
December 30, 2029
Last Updated
November 14, 2025
Record last verified: 2025-11